Metabolomics and Metabolic Diseases: Where Do We Stand?

Cell Metabolism

Volumn 25, Issue 1, 2017, Pages 43-56

  Newgard, Christopher B ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular diseases; diabetes; metabolic diseases; metabolism; metabolomics; obesity

Indexed keywords

BIOLOGICAL MARKER;

CARDIOVASCULAR DISEASE; CYTOLOGY; DISEASE ASSOCIATION; HUMAN; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLITE; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PANCREAS ISLET CELL; PATHOPHYSIOLOGY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; METABOLISM; METABOLOME; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; METABOLIC DISEASES; METABOLOME; METABOLOMICS; MODELS, BIOLOGICAL; TREATMENT OUTCOME;

EID: 85006047652     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.09.018     Document Type: Review

References (109)

1. Abel, E.D., Peroni, O., Kim, J.K., Kim, Y.B., Boss, O., Hadro, E., Minnemann, T., Shulman, G.I., Kahn, B.B., Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409 (2001), 729–733.
2. Allalou, A., Nalla, A., Prentice, K.J., Liu, Y., Zhang, M., Dai, F.F., Ning, X., Osborne, L.R., Cox, B.J., Gunderson, E.P., Wheeler, M.B., A predictive metabolic signature for the transition from gestational diabetes mellitus to type 2 diabetes. Diabetes 65 (2016), 2529–2539.
3. Alves, T.C., Pongratz, R.L., Zhao, X., Yarborough, O., Sereda, S., Shirihai, O., Cline, G.W., Mason, G., Kibbey, R.G., Integrated, step-wise, mass-isotopomeric flux analysis of the TCA cycle. Cell Metab. 22 (2015), 936–947.
4. An, J., Muoio, D.M., Shiota, M., Fujimoto, Y., Cline, G.W., Shulman, G.I., Koves, T.R., Stevens, R., Millington, D., Newgard, C.B., Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 10 (2004), 268–274.
5. Bain, J.R., Stevens, R.D., Wenner, B.R., Ilkayeva, O., Muoio, D.M., Newgard, C.B., Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 58 (2009), 2429–2443.
6. Bentley-Lewis, R., Huynh, J., Xiong, G., Lee, H., Wenger, J., Clish, C., Nathan, D., Thadhani, R., Gerszten, R., Metabolomic profiling in the prediction of gestational diabetes mellitus. Diabetologia 58 (2015), 1329–1332.
7. Bhattacharya, S., Granger, C.B., Craig, D., Haynes, C., Bain, J., Stevens, R.D., Hauser, E.R., Newgard, C.B., Kraus, W.E., Newby, L.K., Shah, S.H., Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization. Atherosclerosis 232 (2014), 191–196.
8. Buescher, J.M., Antoniewicz, M.R., Boros, L.G., Burgess, S.C., Brunengraber, H., Clish, C.B., DeBerardinis, R.J., Feron, O., Frezza, C., Ghesquiere, B., et al. A roadmap for interpreting (13)C metabolite labeling patterns from cells. Curr. Opin. Biotechnol. 34 (2015), 189–201.
9. Cao, H., Gerhold, K., Mayers, J.R., Wiest, M.M., Watkins, S.M., Hotamisligil, G.S., Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134 (2008), 933–944.
10. Chen, T., Ni, Y., Ma, X., Bao, Y., Liu, J., Huang, F., Hu, C., Xie, G., Zhao, A., Jia, W., Jia, W., Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations. Sci. Rep., 6, 2016, 20594.
11. Choi, C.S., Befroy, D.E., Codella, R., Kim, S., Reznick, R.M., Hwang, Y.J., Liu, Z.X., Lee, H.Y., Distefano, A., Samuel, V.T., et al. Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism. Proc. Natl. Acad. Sci. USA 105 (2008), 19926–19931.
12. Chopra, A.R., Louet, J.F., Saha, P., An, J., Demayo, F., Xu, J., York, B., Karpen, S., Finegold, M., Moore, D., et al. Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science 322 (2008), 1395–1399.
13. Clifton, P., Diabetes: treatment of type 2 diabetes mellitus with bariatric surgery. Nat. Rev. Endocrinol. 6 (2010), 191–193.
14. Cobb, J., Eckhart, A., Motsinger-Reif, A., Carr, B., Groop, L., Ferrannini, E., α-hydroxybutryic acid is a selective metabolite biomarker of impaired glucose tolerance. Diabetes Care 39 (2016), 988–995.
15. El-Azzouny, M., Evans, C.R., Treutelaar, M.K., Kennedy, R.T., Burant, C.F., Increased glucose metabolism and glycerolipid formation by fatty acids and GPR40 receptor signaling underlies the fatty acid potentiation of insulin secretion. J. Biol. Chem. 289 (2014), 13575–13588.
16. Fan, J., Ye, J., Kamphorst, J.J., Shlomi, T., Thompson, C.B., Rabinowitz, J.D., Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510 (2014), 298–302.
17. Felig, P., Marliss, E., Cahill, G.F. Jr., Plasma amino acid levels and insulin secretion in obesity. N. Engl. J. Med. 281 (1969), 811–816.
18. Ferdaoussi, M., Dai, X., Jensen, M.V., Wang, R., Peterson, B.S., Huang, C., Ilkayeva, O., Smith, N., Miller, N., Hajmrle, C., et al. Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells. J. Clin. Invest. 125 (2015), 3847–3860.
19. Ferrara, C.T., Wang, P., Neto, E.C., Stevens, R.D., Bain, J.R., Wenner, B.R., Ilkayeva, O.R., Keller, M.P., Blasiole, D.A., Kendziorski, C., et al. Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet., 4, 2008, e1000034.
20. Fontana, L., Cummings, N.E., Arriola Apelo, S.I., Neuman, J.C., Kasza, I., Schmidt, B.A., Cava, E., Spelta, F., Tosti, V., Syed, F.A., et al. Decreased consumption of branched-chain amino acids improves metabolic health. Cell Rep. 16 (2016), 520–530.
21. Frohnert, B.I., Rewers, M.J., Metabolomics in childhood diabetes. Pediatr. Diabetes 17 (2016), 3–14.
22. Gall, W.E., Beebe, K., Lawton, K.A., Adam, K.P., Mitchell, M.W., Nakhle, P.J., Ryals, J.A., Milburn, M.V., Nannipieri, M., Camastra, S., et al., RISC Study Group. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE, 5, 2010, e10883.
23. Glynn, E.L., Piner, L.W., Huffman, K.M., Slentz, C.A., Elliot-Penry, L., AbouAssi, H., White, P.J., Bain, J.R., Muehlbauer, M.J., Ilkayeva, O.R., et al. Impact of combined resistance and aerobic exercise training on branched-chain amino acid turnover, glycine metabolism and insulin sensitivity in overweight humans. Diabetologia 58 (2015), 2324–2335.
24. Goehring, I., Sauter, N.S., Catchpole, G., Assmann, A., Shu, L., Zien, K.S., Moehlig, M., Pfeiffer, A.F.H., Oberholzer, J., Willmitzer, L., et al. Identification of an intracellular metabolic signature impairing beta cell function in the rat beta cell line INS-1E and human islets. Diabetologia 54 (2011), 2584–2594.
25. Gooding, J.R., Jensen, M.V., Dai, X., Wenner, B.R., Lu, D., Arumugam, R., Ferdaoussi, M., MacDonald, P.E., Newgard, C.B., Adenylosuccinate is an insulin secretagogue derived from glucose-induced purine metabolism. Cell Rep. 13 (2015), 157–167.
26. Henquin, J.C., Ravier, M.A., Nenquin, M., Jonas, J.C., Gilon, P., Hierarchy of the beta-cell signals controlling insulin secretion. Eur. J. Clin. Invest. 33 (2003), 742–750.
27. Herman, M.A., She, P., Peroni, O.D., Lynch, C.J., Kahn, B.B., Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J. Biol. Chem. 285 (2010), 11348–11356.
28. Herman, M.A., Peroni, O.D., Villoria, J., Schön, M.R., Abumrad, N.A., Blüher, M., Klein, S., Kahn, B.B., A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 484 (2012), 333–338.
29. Hsiao, G., Chapman, J., Ofrecio, J.M., Wilkes, J., Resnik, J.L., Thapar, D., Subramaniam, S., Sears, D.D., Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats. Am. J. Physiol. Endocrinol. Metab. 300 (2011), E164–E174.
30. Huang, M., Joseph, J.W., Assessment of the metabolic pathways associated with glucose-stimulated biphasic insulin secretion. Endocrinology 155 (2014), 1653–1666.
31. Huang, Y., Cohen, J.C., Hobbs, H.H., Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J. Biol. Chem. 286 (2011), 37085–37093.
32. Huffman, K.M., Shah, S.H., Stevens, R.D., Bain, J.R., Muehlbauer, M., Slentz, C.A., Tanner, C.J., Kuchibhatla, M., Houmard, J.A., Newgard, C.B., Kraus, W.E., Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care 32 (2009), 1678–1683.
33. Illig, T., Gieger, C., Zhai, G., Römisch-Margl, W., Wang-Sattler, R., Prehn, C., Altmaier, E., Kastenmüller, G., Kato, B.S., Mewes, H.W., et al. A genome-wide perspective of genetic variation in human metabolism. Nat. Genet. 42 (2010), 137–141.
34. Ivarsson, R., Quintens, R., Dejonghe, S., Tsukamoto, K., in't Veld, P., Renström, E., Schuit, F.C., Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54 (2005), 2132–2142.
35. Jang, C., Oh, S.F., Wada, S., Rowe, G.C., Liu, L., Chan, M.C., Rhee, J., Hoshino, A., Kim, B., Ibrahim, A., et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat. Med. 22 (2016), 421–426.
36. Jensen, M.V., Joseph, J.W., Ronnebaum, S.M., Burgess, S.C., Sherry, A.D., Newgard, C.B., Metabolic cycling in control of glucose-stimulated insulin secretion. Am. J. Physiol. Endocrinol. Metab. 295 (2008), E1287–E1297.
37. Jin, R., Banton, S., Tran, V.T., Konomi, J.V., Li, S., Jones, D.P., Vos, M.B., Amino acid metabolism is altered in adolescents with nonalcoholic fatty liver disease—an untargeted, high resolution metabolomics study. J. Pediatr. 172 (2016), 14–19.e5.
38. Joseph, J.W., Jensen, M.V., Ilkayeva, O., Palmieri, F., Alárcon, C., Rhodes, C.J., Newgard, C.B., The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion. J. Biol. Chem. 281 (2006), 35624–35632.
39. Koves, T.R., Li, P., An, J., Akimoto, T., Slentz, D., Ilkayeva, O., Dohm, G.L., Yan, Z., Newgard, C.B., Muoio, D.M., Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem. 280 (2005), 33588–33598.
40. Koves, T.R., Ussher, J.R., Noland, R.C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J.R., Newgard, C.B., et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7 (2008), 45–56.
41. Kraus, W.E., Muoio, D.M., Stevens, R., Craig, D., Bain, J.R., Grass, E., Haynes, C., Kwee, L., Qin, X., Slentz, D.H., et al. Metabolomic quantitative trait loci (mQTL) mapping implicates the ubiquitin proteasome system in cardiovascular disease pathogenesis. PLoS Genet., 11, 2015, e1005553.
42. Laeger, T., Henagan, T.M., Albarado, D.C., Redman, L.M., Bray, G.A., Noland, R.C., Münzberg, H., Hutson, S.M., Gettys, T.W., Schwartz, M.W., Morrison, C.D., FGF21 is an endocrine signal of protein restriction. J. Clin. Invest. 124 (2014), 3913–3922.
43. Laferrère, B., Reilly, D., Arias, S., Swerdlow, N., Gorroochurn, P., Bawa, B., Bose, M., Teixeira, J., Stevens, R.D., Wenner, B.R., et al. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci. Transl. Med., 3, 2011, 80re2.
44. Lallukka, S., Yki-Järvinen, H., Non-alcoholic fatty liver disease and risk of type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 30 (2016), 385–395.
45. Liu, Y., Prentice, K.J., Eversley, J.A., Hu, C., Batchuluun, B., Leavey, K., Hansen, J.B., Wei, D.W., Cox, B., Dai, F.F., et al. Rapid elevation in CMPF may act as a tipping point in diabetes development. Cell Rep. 14 (2016), 2889–2900.
46. Lorenz, M.A., El Azzouny, M.A., Kennedy, R.T., Burant, C.F., Metabolome response to glucose in the β-cell line INS-1 832/13. J. Biol. Chem. 288 (2013), 10923–10935.
47. Louet, J.F., Chopra, A.R., Sagen, J.V., An, J., York, B., Tannour-Louet, M., Saha, P.K., Stevens, R.D., Wenner, B.R., Ilkayeva, O.R., et al. The coactivator SRC-1 is an essential coordinator of hepatic glucose production. Cell Metab. 12 (2010), 606–618.
48. Lu, D., Mulder, H., Zhao, P., Burgess, S.C., Jensen, M.V., Kamzolova, S., Newgard, C.B., Sherry, A.D., 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc. Natl. Acad. Sci. USA 99 (2002), 2708–2713.
49. Luukkonen, P.K., Zhou, Y., Sädevirta, S., Leivonen, M., Arola, J., Orešič, M., Hyötyläinen, T., Yki-Järvinen, H., Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J. Hepatol. 64 (2016), 1167–1175.
50. Magkos, F., Bradley, D., Schweitzer, G.G., Finck, B.N., Eagon, J.C., Ilkayeva, O., Newgard, C.B., Klein, S., Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on branched-chain amino acid metabolism. Diabetes 62 (2013), 2757–2761.
51. Magnusson, M., Lewis, G.D., Ericson, U., Orho-Melander, M., Hedblad, B., Engström, G., Ostling, G., Clish, C., Wang, T.J., Gerszten, R.E., Melander, O., A diabetes-predictive amino acid score and future cardiovascular disease. Eur. Heart J. 34 (2013), 1982–1989.
52. Marso, S.P., Daniels, G.H., Brown-Frandsen, K., Kristensen, P., Mann, J.F., Nauck, M.A., Nissen, S.E., Pocock, S., Poulter, N.R., Ravn, L.S., et al. LEADER Steering Committee, LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 375 (2016), 311–322.
53. McCormack, S.E., Shaham, O., McCarthy, M.A., Deik, A.A., Wang, T.J., Gerszten, R.E., Clish, C.B., Mootha, V.K., Grinspoon, S.K., Fleischman, A., Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr. Obes. 8 (2013), 52–61.
54. Menni, C., Fauman, E., Erte, I., Perry, J.R.B., Kastenmüller, G., Shin, S.-Y., Petersen, A.-K., Hyde, C., Psatha, M., Ward, K.J., et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 62 (2013), 4270–4276.
55. Michaliszyn, S.F., Sjaarda, L.A., Mihalik, S.J., Lee, S., Bacha, F., Chace, D.H., De Jesus, V.R., Vockley, J., Arslanian, S.A., Metabolomic profiling of amino acids and β-cell function relative to insulin sensitivity in youth. J. Clin. Endocrinol. Metab. 97 (2012), E2119–E2124.
56. Muoio, D.M., Noland, R.C., Kovalik, J.P., Seiler, S.E., Davies, M.N., DeBalsi, K.L., Ilkayeva, O.R., Stevens, R.D., Kheterpal, I., Zhang, J., et al. Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab. 15 (2012), 764–777.
57. Newbern, D., Gumus Balikcioglu, P., Balikcioglu, M., Bain, J., Muehlbauer, M., Stevens, R., Ilkayeva, O., Dolinsky, D., Armstrong, S., Irizarry, K., Freemark, M., Sex differences in biomarkers associated with insulin resistance in obese adolescents: metabolomic profiling and principal components analysis. J. Clin. Endocrinol. Metab. 99 (2014), 4730–4739.
58. Newgard, C.B., Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 15 (2012), 606–614.
59. Newgard, C.B., Attie, A.D., Getting biological about the genetics of diabetes. Nat. Med. 16 (2010), 388–391.
60. Newgard, C.B., An, J., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Lien, L.F., Haqq, A.M., Shah, S.H., Arlotto, M., Slentz, C.A., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9 (2009), 311–326.
61. O'Rahilly, S., Human genetics illuminates the paths to metabolic disease. Nature 462 (2009), 307–314.
62. Oh, D.Y., Talukdar, S., Bae, E.J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W.J., Watkins, S.M., Olefsky, J.M., GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142 (2010), 687–698.
63. Palmer, N.D., Stevens, R.D., Antinozzi, P.A., Anderson, A., Bergman, R.N., Wagenknecht, L.E., Newgard, C.B., Bowden, D.W., Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. J. Clin. Endocrinol. Metab. 100 (2015), E463–E468.
64. Patti, G.J., Yanes, O., Siuzdak, G., Innovation: Metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 13 (2012), 263–269.
65. Pedersen, H.K., Gudmundsdottir, V., Nielsen, H.B., Hyotylainen, T., Nielsen, T., Jensen, B.A.H., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., et al., MetaHIT Consortium. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535 (2016), 376–381.
66. Perng, W., Gillman, M.W., Fleisch, A.F., Michalek, R.D., Watkins, S.M., Isganaitis, E., Patti, M.-E., Oken, E., Metabolomic profiles and childhood obesity. Obesity (Silver Spring) 22 (2014), 2570–2578.
67. Prentice, K.J., Luu, L., Allister, E.M., Liu, Y., Jun, L.S., Sloop, K.W., Hardy, A.B., Wei, L., Jia, W., Fantus, I.G., et al. The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction. Cell Metab. 19 (2014), 653–666.
68. Retnakaran, R., Ye, C., Kramer, C.K., Connelly, P.W., Hanley, A.J., Sermer, M., Zinman, B., Evaluation of circulating determinants of beta-cell function in women with and without gestational diabetes. J. Clin. Endocrinol. Metab. 101 (2016), 2683–2691.
69. Rhee, E.P., Cheng, S., Larson, M.G., Walford, G.A., Lewis, G.D., McCabe, E., Yang, E., Farrell, L., Fox, C.S., O'Donnell, C.J., et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J. Clin. Invest. 121 (2011), 1402–1411.
70. Rhee, E.P., Ho, J.E., Chen, M.-H., Shen, D., Cheng, S., Larson, M.G., Ghorbani, A., Shi, X., Helenius, I.T., O'Donnell, C.J., et al. A genome-wide association study of the human metabolome in a community-based cohort. Cell Metab. 18 (2013), 130–143.
71. Rhee, E.P., Yang, Q., Yu, B., Liu, X., Cheng, S., Deik, A., Pierce, K.A., Bullock, K., Ho, J.E., Levy, D., et al. An exome array study of the plasma metabolome. Nat. Commun., 7, 2016, 12360.
72. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
73. Roberts, L.D., Boström, P., O'Sullivan, J.F., Schinzel, R.T., Lewis, G.D., Dejam, A., Lee, Y.K., Palma, M.J., Calhoun, S., Georgiadi, A., et al. β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. 19 (2014), 96–108.
74. Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L.A., Boerwinkle, E., Cohen, J.C., Hobbs, H.H., Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40 (2008), 1461–1465.
75. Ronnebaum, S.M., Ilkayeva, O., Burgess, S.C., Joseph, J.W., Lu, D., Stevens, R.D., Becker, T.C., Sherry, A.D., Newgard, C.B., Jensen, M.V., A pyruvate cycling pathway involving cytosolic NAPD-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J. Biol. Chem. 281 (2006), 30593–30602.
76. Scholtens, D.M., Muehlbauer, M.J., Daya, N.R., Stevens, R.D., Dyer, A.R., Lowe, L.P., Metzger, B.E., Newgard, C.B., Bain, J.R., Lowe, W.L. Jr., HAPO Study Cooperative Research Group. Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy. Diabetes Care 37 (2013), 158–166.
77. Scholtens, D.M., Bain, J.R., Reisetter, A.C., Muehlbauer, M.J., Nodzenski, M., Stevens, R.D., Ilkayeva, O., Lowe, L.P., Metzger, B.E., Newgard, C.B., Lowe, W.L. Jr., HAPO Study Cooperative Research Group. Metabolic networks and metabolites underlie associations between maternal glucose during pregnancy and newborn size at birth. Diabetes 65 (2016), 2039–2050.
78. Schuit, F., De Vos, A., Farfari, S., Moens, K., Pipeleers, D., Brun, T., Prentki, M., Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J. Biol. Chem. 272 (1997), 18572–18579.
79. Shah, S.H., Hauser, E.R., Bain, J.R., Muehlbauer, M.J., Haynes, C., Stevens, R.D., Wenner, B.R., Dowdy, Z.E., Granger, C.B., Ginsburg, G.S., et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol. Syst. Biol. 5 (2009), 258–266.
80. Shah, S.H., Bain, J.R., Muehlbauer, M.J., Stevens, R.D., Crosslin, D.R., Haynes, C., Dungan, J., Newby, L.K., Hauser, E.R., Ginsburg, G.S., et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet 3 (2010), 207–214.
81. Shah, A.A., Craig, D.M., Sebek, J.K., Haynes, C., Stevens, R.C., Muehlbauer, M.J., Granger, C.B., Hauser, E.R., Newby, L.K., Newgard, C.B., et al. Metabolic profiles predict adverse events after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 143 (2012), 873–878.
82. Shah, S.H., Crosslin, D.R., Haynes, C.S., Nelson, S., Turer, C.B., Stevens, R.D., Muehlbauer, M.J., Wenner, B.R., Bain, J.R., Laferrère, B., et al. Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 55 (2012), 321–330.
83. Shah, S.H., Kraus, W.E., Newgard, C.B., Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation 126 (2012), 1110–1120.
84. Shah, S.H., Sun, J.L., Stevens, R.D., Bain, J.R., Muehlbauer, M.J., Pieper, K.S., Haynes, C., Hauser, E.R., Kraus, W.E., Granger, C.B., et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am. Heart J. 163 (2012), 844–850.e1.
85. She, P., Van Horn, C., Reid, T., Hutson, S.M., Cooney, R.N., Lynch, C.J., Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am. J. Physiol. Endocrinol. Metab. 293 (2007), E1552–E1563.
86. Shepherd, P.R., Gnudi, L., Tozzo, E., Yang, H., Leach, F., Kahn, B.B., Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J. Biol. Chem. 268 (1993), 22243–22246.
87. Sherif, Z.A., Saeed, A., Ghavimi, S., Nouraie, S.-M., Laiyemo, A.O., Brim, H., Ashktorab, H., Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations. Dig. Dis. Sci. 61 (2016), 1214–1225.
88. Shin, S.Y., Fauman, E.B., Petersen, A.-K., Krumsiek, J., Santos, R., Huang, J., Arnold, M., Erte, I., Forgetta, V., Yang, T.-P., et al., Multiple Tissue Human Expression Resource (MuTHER) Consortium. An atlas of genetic influences on human blood metabolites. Nat. Genet. 46 (2014), 543–550.
89. Smagris, E., BasuRay, S., Li, J., Huang, Y., Lai, K.M., Gromada, J., Cohen, J.C., Hobbs, H.H., Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 61 (2015), 108–118.
90. Spégel, P., Sharoyko, V.V., Goehring, I., Danielsson, A.P., Malmgren, S., Nagorny, C.L., Andersson, L.E., Koeck, T., Sharp, G.W., Straub, S.G., et al. Time-resolved metabolomics analysis of β-cells implicates the pentose phosphate pathway in the control of insulin release. Biochem. J. 450 (2013), 595–605.
91. Suhre, K., Shin, S.Y., Petersen, A.K., Mohney, R.P., Meredith, D., Wägele, B., Altmaier, E., Deloukas, P., Erdmann, J., Grundberg, E., et al., CARDIoGRAM. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477 (2011), 54–60.
92. Tai, E.S., Tan, M.L., Stevens, R.D., Low, Y.L., Muehlbauer, M.J., Goh, D.L., Ilkayeva, O.R., Wenner, B.R., Bain, J.R., Lee, J.J., et al. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 53 (2010), 757–767.
93. Thalacker-Mercer, A.E., Ingram, K.H., Guo, F., Ilkayeva, O., Newgard, C.B., Garvey, W.T., BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans. Diabetes 63 (2014), 791–800.
94. Wahl, S., Yu, Z., Kleber, M., Singmann, P., Holzapfel, C., He, Y., Mittelstrass, K., Polonikov, A., Prehn, C., Römisch-Margl, W., et al. Childhood obesity is associated with changes in the serum metabolite profile. Obes. Facts 5 (2012), 660–670.
95. Walford, G.A., Davis, J., Warner, A.S., Ackerman, R.J., Billings, L.K., Chamarthi, B., Fanelli, R.R., Hernandez, A.M., Huang, C., Khan, S.Q., et al. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus. Metabolism 62 (2013), 1772–1778.
96. Wang, T.J., Larson, M.G., Vasan, R.S., Cheng, S., Rhee, E.P., McCabe, E., Lewis, G.D., Fox, C.S., Jacques, P.F., Fernandez, C., et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17 (2011), 448–453.
97. Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., Feldstein, A.E., Britt, E.B., Fu, X., Chung, Y.M., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
98. Wang, T.J., Ngo, D., Psychogios, N., Dejam, A., Larson, M.G., Vasan, R.S., Ghorbani, A., O'Sullivan, J., Cheng, S., Rhee, E.P., et al. 2-aminoadipic acid is a biomarker for diabetes risk. J. Clin. Invest. 123 (2013), 4309–4317.
99. Wang, Z., Roberts, A.B., Buffa, J.A., Levison, B.S., Zhu, W., Org, E., Gu, X., Huang, Y., Zamanian-Daryoush, M., Culley, M.K., et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163 (2015), 1585–1595.
100. White, P.J., Lapworth, A.L., An, J., Wang, L., McGarrah, R.W., Stevens, R.D., Ilkayeva, O., George, T., Muehlbauer, M.J., Bain, J.R., et al. Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export. Mol. Metab. 5 (2016), 538–551.
101. Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E., et al. HMDB 3.0—The Human Metabolome Database in 2013. Nucleic Acids Res. 41 (2013), D801–D807.
102. Wong, K.E., Mikus, C.R., Slentz, D.H., Seiler, S.E., DeBalsi, K.L., Ilkayeva, O.R., Crain, K.I., Kinter, M.T., Kien, C.L., Stevens, R.D., Muoio, D.M., Muscle-specific overexpression of PGC-1α does not augment metabolic improvements in response to exercise and caloric restriction. Diabetes 64 (2015), 1532–1543.
103. Würtz, P., Mäkinen, V.-P., Soininen, P., Kangas, A.J., Tukiainen, T., Kettunen, J., Savolainen, M.J., Tammelin, T., Viikari, J.S., Rönnemaa, T., et al. Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes 61 (2012), 1372–1380.
104. Würtz, P., Soininen, P., Kangas, A.J., Rönnemaa, T., Lehtimäki, T., Kähönen, M., Viikari, J.S., Raitakari, O.T., Ala-Korpela, M., Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 36 (2013), 648–655.
105. Yore, M.M., Syed, I., Moraes-Vieira, P.M., Zhang, T., Herman, M.A., Homan, E.A., Patel, R.T., Lee, J., Chen, S., Peroni, O.D., et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 159 (2014), 318–332.
106. York, B., Reineke, E.L., Sagen, J.V., Nikolai, B.C., Zhou, S., Louet, J.-F., Chopra, A.R., Chen, X., Reed, G., Noebels, J., et al. Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. Cell Metab. 15 (2012), 752–763.
107. Zamboni, N., Saghatelian, A., Patti, G.J., Defining the metabolome: Size, flux, and regulation. Mol. Cell 58 (2015), 699–706.
108. Zhu, W., Gregory, J.C., Org, E., Buffa, J.A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165 (2016), 111–124.
109. Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O.E., Woerle, H.J., et al., EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373 (2015), 2117–2128.